MarketPeel
Insider Trading Intelligence
PD

Pravin Dugel

OCUL
SEE REMARKS · OCULAR THERAPEUTIX, INC · CIK 0001700917
FILING MIX · LIFETIME39%/61%
BUYS
11
SELLS
17
TOTAL VALUE
$2.76M
COMPANIES
1
ACTIVE SINCE
Feb 2024
HOLDINGS NOW
2,547,078
AVG SELL PX
$8.82
TRADE KIND
SHOWING 28 / 28
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
9 backtested trades · 8 horizons · 14 pending
Forward-return performance of every backtestable P/S trade by Pravin Dugel, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d9+44.44%+1.57%+0.29%+1.28%+0.64%
14d9+22.22%+9.59%+0.01%+9.57%+6.09%
30d9+44.44%+3.07%+0.58%+2.49%+2.80%
60d9+44.44%+12.50%+2.98%+9.52%+8.22%
90d9+44.44%+8.07%+4.41%+4.95%-4.56%
180d9(2 pending)+57.14%+13.69%+8.39%+13.19%+11.81%
1y9(4 pending)+0.00%+27.52%+16.94%+10.57%+17.82%
2y9(8 pending)+0.00%+38.45%+42.93%-4.48%-4.48%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
OCUL · 2,547,078 shares · as of Jun 16, 2026
0885,4481,770,8972,656,3453,541,79320252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 11 buys / 17 sellsCOVERAGE · 10 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
OCUL
OCULAR THERAPEUTIX, INC
SALEGRANT
Gift
50,0922,547,078Jun 16, 2026Jun 18, 2026View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Gift
50,09250,092Jun 16, 2026Jun 18, 2026View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Gift
394,696694,811May 28, 2026May 28, 2026View →
OCUL
OCULAR THERAPEUTIX, INC
SALEGRANT
Gift
394,6960May 28, 2026May 28, 2026View →
OCUL
OCULAR THERAPEUTIX, INC
SALE10b5-1
10b5-1 plan
21,156$8.20$173.5K2,597,170May 26, 2026May 28, 2026View →
OCUL
OCULAR THERAPEUTIX, INC
SALEGRANT
Gift
394,6962,618,326Apr 9, 2026Apr 13, 2026View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Gift
394,696394,696Apr 9, 2026Apr 13, 2026View →
OCUL
OCULAR THERAPEUTIX, INC
SALE10b5-1
10b5-1 plan
20,056$8.28$166.1K3,013,022Feb 23, 2026Feb 25, 2026View →
OCUL
OCULAR THERAPEUTIX, INC
SALE10b5-1
10b5-1 plan
124,882$9.04$1.13M3,033,078Feb 12, 2026Feb 17, 2026View →
OCUL
OCULAR THERAPEUTIX, INC
SALEGRANT
Gift
49,7540Nov 26, 2025Nov 26, 2025View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Gift
49,754300,115Nov 26, 2025Nov 26, 2025View →
OCUL
OCULAR THERAPEUTIX, INC
SALE10b5-1
10b5-1 plan
19,530$12.04$235.1K3,157,960Nov 24, 2025Nov 26, 2025View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Gift
49,75449,754Sep 9, 2025Sep 11, 2025View →
OCUL
OCULAR THERAPEUTIX, INC
SALEGRANT
Gift
49,7543,177,490Sep 9, 2025Sep 11, 2025View →
OCUL
OCULAR THERAPEUTIX, INC
SALE10b5-1
10b5-1 plan
21,494$12.04$258.8K3,227,244Aug 25, 2025Aug 27, 2025View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Gift
250,361250,361Aug 11, 2025Aug 13, 2025View →
OCUL
OCULAR THERAPEUTIX, INC
SALEGRANT
Gift
50,0293,248,738Jun 12, 2025Aug 13, 2025View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Stock grant
2,750,0002,750,000Jun 11, 2025Jun 13, 2025View →
OCUL
OCULAR THERAPEUTIX, INC
SALE10b5-1
10b5-1 plan
21,219$7.18$152.4K3,499,099May 23, 2025May 27, 2025View →
OCUL
OCULAR THERAPEUTIX, INC
SALEGRANT
Gift
200,3323,298,767Apr 28, 2025Aug 13, 2025View →
OCUL
OCULAR THERAPEUTIX, INC
SALE10b5-1
10b5-1 plan
21,475$6.87$147.5K3,520,318Feb 24, 2025Feb 26, 2025View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Stock grant
1,250,0002,041,793Feb 11, 2025Feb 13, 2025View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Stock grant
1,500,0003,541,793Feb 11, 2025Feb 13, 2025View →
OCUL
OCULAR THERAPEUTIX, INC
SALE10b5-1
10b5-1 plan
20,680$9.01$186.3K791,793Nov 25, 2024Nov 27, 2024View →
OCUL
OCULAR THERAPEUTIX, INC
SALE10b5-1
10b5-1 plan
20,880$9.02$188.3K812,473Aug 23, 2024Aug 27, 2024View →
OCUL
OCULAR THERAPEUTIX, INC
SALE10b5-1
10b5-1 plan
21,626$5.79$125.2K833,353May 23, 2024May 28, 2024View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Stock grant
854,979854,979Feb 22, 2024Feb 26, 2024View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Stock grant
1,282,4691,282,469Feb 22, 2024Feb 26, 2024View →
Other insiders · OCUL
Loading peer insiders…
About this filer
CIK 0001700917
ROLE
See Remarks
PRIMARY
OCUL
COMPANIES
1
ACTIVE SINCE
Feb 2024
MARKETPEEL · /INSIDER/0001700917DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback